Association between Intracellular Infectious Agents and Schizophrenia
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: A number of studies have reported association between Toxoplasma gondii (T. gondii ) and Chlamydia infection and the risk of schizophrenia. The aim of the present study was to compare the prevalence of T. gondii and Chlamydia infection between the schizophrenia and normal control subjects and to compare the clinical features between seropositive and seronegative schizophrenia patients. Methods: The rate of serum reactivity to T. gondii, Chlamydia trachomatis (C. trachomatis ), Chlamydia pneumonia in 96 schizophrenia and 50 control subjects was investigated using enzyme-linked immunosorbent assay and indirect fluorescent antibody technique. The clinical symptoms of the schizophrenia patients were scored with Positive and Negative Syndrome Scale and a comparative analysis was carried out. Results: A significant positive association between immunoglobulin G (IgG) antibodies to T. gondii and C. trachomatis in schizophrenia was found, and the odds ratio of schizophrenia associated with IgG antibody was found to be 3.22 and 2.86, respectively. The Toxoplasma-seropositive schizophrenia patient had higher score on the negative subscale N1 and N7 and general psychopathology subscale G13, while C. trachomatis-seropositive schizophrenia patient had higher score on the general psychopathology subscale G10. Conclusion: The results from the present study suggest significant association between T. gondii, C. trachomatis infection and schizophrenia. In future, further studies are needed to elucidate the correlation between the two types of infection and schizophrenia.
Abstract
Objective: A number of studies have reported association between Toxoplasma gondii (T. gondii ) and Chlamydia infection and the risk of schizophrenia. The aim of the present study was to compare the prevalence of T. gondii and Chlamydia infection between the schizophrenia and normal control subjects and to compare the clinical features between seropositive and seronegative schizophrenia patients. Methods: The rate of serum reactivity to T. gondii, Chlamydia trachomatis (C. trachomatis ), Chlamydia pneumonia in 96 schizophrenia and 50 control subjects was investigated using enzyme-linked immunosorbent assay and indirect fluorescent antibody technique. The clinical symptoms of the schizophrenia patients were scored with Positive and Negative Syndrome Scale and a comparative analysis was carried out. Results: A significant positive association between immunoglobulin G (IgG) antibodies to T. gondii and C. trachomatis in schizophrenia was found, and the odds ratio of schizophrenia associated with IgG antibody was found to be 3.22 and 2.86, respectively. The Toxoplasma-seropositive schizophrenia patient had higher score on the negative subscale N1 and N7 and general psychopathology subscale G13, while C. trachomatis-seropositive schizophrenia patient had higher score on the general psychopathology subscale G10. Conclusion: The results from the present study suggest significant association between T. gondii, C. trachomatis infection and schizophrenia. In future, further studies are needed to elucidate the correlation between the two types of infection and schizophrenia.
참고문헌 (26)
- Brown AS, "Prenatal infection as a risk factor for schizophrenia", Schizophr Bull, 32, pp.200~202 (2006)
- Fuller Torrey E, "Familial and genetic mechanisms in schizophrenia", Brain Res Brain Res Rev, 31, pp.113~117 (2000)
- Wang HL, "Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia", Acta Psychiatr Scand, 114, pp.40~48 (2006)
- Torrey EF, "Antibodies to Toxoplasma gondii in patients with schizophrenia: a metaanalysis", Schizophr Bull, 33, pp.729~736 (2007)
- Montoya JG, "Toxoplasmosis", Lancet, 363, pp.1965~1976 (2004)
- Estran C, "Toxoplasma gondii in human astrocytes in vitro: interleukin (IL)-12 and IL-10 do not influence cystogenesis", J Parasitol, 92, pp.1108~1110 (2006)
- Yolken RH, "Are some cases of psychosis caused by microbial agents? A review of the evidence", Mol Psychiatry, 13, pp.470~479 (2008)
- Brown AS, "Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring", Am J Psychiatry, 162, pp.767~773 (2005)
- Niebuhr DW, "Selected infectious agents and risk of schizophrenia among U.S. Military personnel", Am J Psychiatry, 165, pp.99~106 (2008)
- Phee SS, "Antibody titers of Toxoplasma gondii among patients with mental disorders", J Wonkwang Med Sci, 15, pp.33~42 (1999)
- Everett KD, "Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms", Int J Syst Bacteriol, 49(2), pp.415~440 (1999)
- Kaur C, "From blood to brain: amoeboid microglial cell, a nascent macrophage and its functions in developing brain", Acta Pharmacol Sin, 28, pp.1087~1096 (2007)
- Fellerhoff B, "High risk of schizophrenia and other mental disorders associated with chlamydial infections: hypothesis to combine drug treatment and adoptive immunotherapy", Med Hypotheses, 65, pp.243~252 (2005)
- Fellerhoff B, "Increased prevalence of Chlamydophila DNA in post-mortem brain frontal cortex from patients with schizophrenia", Schizophr Res, 129, pp.191~195 (2011)
- Frykholm BO, "On the question of infectious aetiologies for multiple sclerosis, schizophrenia and the chronic fatigue syndrome and their treatment with antibiotics", Med Hypotheses, 72, pp.736~739 (2009)
- Kay SR, "The positive and negative syndrome scale (PANSS) for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)
- Kim CY, "Psychiatric assessment instruments", pp.61~62 (2001), Hana Medical Press
- Yolken RH, "Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia", Clin Infect Dis, 32, pp.842~844 (2001)
- Krause D, "The association of infectious agents and schizophrenia", World J Biol Psychiatry, 11, pp.739~743 (2010)
- Choi TY, "Prevalence of specific antibodies to Chlamydia pneumoniae in Korea", J Clin Microbiol, 36, pp.3426~3428 (1998)
- Haynes BF, "Introduction to the immune system, In Harrison’s principles of internal medicine", pp.1907~1930 (2005), McGraw Hill
- Brown AS, "Prenatal exposure to maternal infection and executive dysfunction in adult schizophrenia", Am J Psychiatry, 166, pp.683~690 (2009)
- Miüller N, "The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view", J Neural Transm Suppl, 72, pp.269~280 (2007)
- Hariri AG, "Sexual problems in a sample of the Turkish psychiatric population", Compr Psychiatry, 50, pp.353~360 (2009)
- Myint AM, "Neuropsychiatric disorders related to interferon and interleukins treatment", Metab Brain Dis, 24, pp.55~68 (2009)
- Carlsson A, "The neurochemical circuitry of schizophrenia", Pharmacopsychiatry, 39(Suppl 1), pp.S10~S14 (2006)